Infectious Diseases Diagnostics Market

Global Market Study on Infectious Diseases Diagnostics: STDs to Remain Largest Segment; APAC Continues Dominance, Followed by MEA

Infectious Diseases Diagnostics Market Segmented By CNS Infection, Diarrheal Diseases, Respiratory Infections, Blood Infections, Sexually Transmitted Diseases Indication with ELISA, Polymerase Chain Reaction, Immunoassays, Cell Cultures Technique

  • September-2020
  • PMRREP11413
  • 241 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

2. Assumptions and Acronyms

3. Research Methodology

4. Infectious Disease Diagnostics Market Overview

    4.1. Introduction

        4.1.1. Infectious Disease Diagnostics Market Definition

        4.1.2. Infectious Disease Diagnostics Market Taxonomy

    4.2. Infectious Disease Diagnostics Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunities

        4.2.4. Trends

5. Global Infectious Disease Diagnostics Market Analysis, By Disease Indication

    5.1. Introduction

        5.1.1. Y-o-Y Growth Comparison, By Disease Indication

        5.1.2. Market Share & Basis Point (BPS) Analysis, By Disease Indication

    5.2. Market Forecast, By Disease Indication

        5.2.1. CNS Infection

            5.2.1.1. Absolute $ Opportunity

            5.2.1.2. Market Value (US$ Mn) Forecast

            5.2.1.3. Meningitis

            5.2.1.4. Brain Abscess

        5.2.2. Diarrheal Diseases

            5.2.2.1. Absolute $ Opportunity

            5.2.2.2. Market Value (US$ Mn) Forecast

            5.2.2.3. Shigellosis

            5.2.2.4. Cholera

            5.2.2.5. Enteric/Typhoid Fever

        5.2.3. Respiratory Infections

            5.2.3.1. Absolute $ Opportunity

            5.2.3.2. Market Value (US$ Mn) Forecast

            5.2.3.3. Tuberculosis

            5.2.3.4. Influenza

            5.2.3.5. Bronchitis

        5.2.4. Blood Infections

            5.2.4.1. Absolute $ Opportunity

            5.2.4.2. Market Value (US$ Mn) Forecast

            5.2.4.3. Malaria

            5.2.4.4. Dengue

            5.2.4.5. Infectious Mononucleosis

            5.2.4.6. Others

        5.2.5. Sexually Transmitted Diseases

            5.2.5.1. Absolute $ Opportunity

            5.2.5.2. Market Value (US$ Mn) Forecast

            5.2.5.3. Chlamydia

            5.2.5.4. AIDS

            5.2.5.5. Syphilis

            5.2.5.6. Others

    5.3. Market Attractiveness Analysis, By Disease Indication

 

6. Global Infectious Disease Diagnostics Market Analysis, By Technique

    6.1. Introduction

        6.1.1. Y-o-Y Growth Comparison, By Technique

        6.1.2. Market Share & Basis Point (BPS) Analysis, By Technique

    6.2. Market Forecast, By Technique

        6.2.1. ELISA

            6.2.1.1. Absolute $ Opportunity

            6.2.1.2. Market Value (US$ Mn) Forecast

        6.2.2. Polymerase Chain Reaction

            6.2.2.1. Absolute $ Opportunity

            6.2.2.2. Market Value (US$ Mn) Forecast

        6.2.3. Immunoassays

            6.2.3.1. Absolute $ Opportunity

            6.2.3.2. Market Value (US$ Mn) Forecast

        6.2.4. Cell Cultures

            6.2.4.1. Absolute $ Opportunity

            6.2.4.2. Market Value (US$ Mn) Forecast

        6.2.5. Others

            6.2.5.1. Absolute $ Opportunity

            6.2.5.2. Market Value (US$ Mn) Forecast

    6.3. arket Attractiveness Analysis, By Technique

 7. Global Infectious Disease Diagnostics Market Analysis, By End User

    7.1. Introduction

        7.1.1. Y-o-Y Growth Comparison, By End User

        7.1.2. Market Share & Basis Point (BPS) Analysis, By End User

    7.2. Market Forecast, By End User

        7.2.1. Hospitals

            7.2.1.1. Absolute $ Opportunity

            7.2.1.2. Market Value (US$ Mn) Forecast

        7.2.2. Diagnostic Centers

            7.2.2.1. Absolute $ Opportunity

            7.2.2.2. Market Value (US$ Mn) Forecast

        7.2.3. Clinics

            7.2.3.1. Absolute $ Opportunity

            7.2.3.2. Market Value (US$ Mn) Forecast

        7.2.4. Government Organisations

            7.2.4.1. Absolute $ Opportunity

            7.2.4.2. Market Value (US$ Mn) Forecast

    7.3. Market Attractiveness Analysis, By End User

8. Global Infectious Disease Diagnostics Market Analysis, By Region

    8.1. Introduction

        8.1.1. Y-o-Y Growth Projections, By Region

        8.1.2. Market Share & Basis Point (BPS) Analysis, By Region

    8.2. Market Forecast, By Region

        8.2.1. North America Market Value (US$ Mn) Forecast

        8.2.2. Latin America Market Value (US$ Mn) Forecast

        8.2.3. Europe Market Value (US$ Mn) Forecast

        8.2.4. APAC Market Value (US$ Mn) Forecast

        8.2.5. MEA Market Value (US$ Mn) Forecast

    8.3. Regional Attractiveness Analysis

9. North America Infectious Disease Diagnostics Market Analysis

    9.1. Introduction

        9.1.1. Y-o-Y Growth Projections, By Country

        9.1.2. Market Share & Basis Point (BPS) Analysis, By Country

    9.2. Key Trends

    9.3. North America Market Forecast

        9.3.1. Market Value (US$ Mn) Forecast, By Country

            9.3.1.1. U.S. Absolute $ Opportunity

            9.3.1.2. Canada Absolute $ Opportunity

        9.3.2. Market Value (US$ Mn) Forecast, By Disease Indication

            9.3.2.1. CNS Infection

                9.3.2.1.1. Meningitis

                9.3.2.1.2. Brain Abscess

            9.3.2.2. Diarrheal Diseases

                9.3.2.2.1. Shigellosis

                9.3.2.2.2. Cholera

                9.3.2.2.3. Typhoid Fever

            9.3.2.3. Respiratory Infections

                9.3.2.3.1. Tuberculosis

                9.3.2.3.2. Influenza

                9.3.2.3.3. Bronchitis

            9.3.2.4. Blood Infections

                9.3.2.4.1. Malaria

                9.3.2.4.2. Dengue

                9.3.2.4.3. Infectious Mononucleosis

                9.3.2.4.4. Others

            9.3.2.5. Sexually Transmitted Diseases

                9.3.2.5.1. Chlamydia

                9.3.2.5.2. AIDS

                9.3.2.5.3. Syphilis

                9.3.2.5.4. Others

        9.3.3. Market Value (US$ Mn) Forecast, By End User

            9.3.3.1. Hospitals

            9.3.3.2. Diagnostic Centers

            9.3.3.3. Clinics

            9.3.3.3. Government Organisations

        9.3.4. Market Value (US$ Mn) Forecast, By Technique

            9.3.4.1. ELISA

            9.3.4.2. Polymerase Chain Reaction

            9.3.4.3. Immunoassays

            9.3.4.4. Cell Cultures

            9.3.4.5. Others

    9.4. Market Attractiveness Analysis

        9.4.1. By Country

        9.4.2. By Disease Indication

        9.4.3. By Technique

        9.4.4. By End User

10. Latin America Infectious Disease Diagnostics Market Analysis

    10.1. Introduction

        10.1.1. Y-o-Y Growth Projections, By Country

        10.1.2. Market Share & Basis Point (BPS) Analysis, By Country

    10.2. Key Trends

    10.3. Latin America Market Forecast

        10.3.1. Market Value (US$ Mn) Forecast, By Country

                10.3.1.1. Brazil Absolute $ Opportunity

                10.3.1.2. Mexico Absolute $ Opportunity

                10.3.1.3. Rest of Latin America Absolute $ Opportunity

        10.3.2. Market Value (US$ Mn) Forecast, By Disease Indication

            10.3.2.1. CNS Infection

                10.3.2.1.1. Meningitis

                10.3.2.1.2. Brain Abscess

            10.3.2.2. Diarrheal Diseases

                10.3.2.2.1. Shigellosis

                10.3.2.2.2. Cholera

                10.3.2.2.3. Typhoid Fever

            10.3.2.3. Respiratory Infections

                10.3.2.3.1. Tuberculosis

                10.3.2.3.2. Influenza

                10.3.2.3.3. Bronchitis

            10.3.2.4. Blood Infections

                10.3.2.4.1. Malaria

                10.3.2.4.2. Dengue

                10.3.2.4.3. Infectious Mononucleosis

                10.3.2.4.4. Others

            10.3.2.5. Sexually Transmitted Diseases

                10.3.2.5.1. Chlamydia

                10.3.2.5.2. AIDS

                10.3.2.5.3. Syphilis

                10.3.2.5.4. Others

        10.3.3. Market Value (US$ Mn) Forecast, By End User

            10.3.3.1. Hospitals

            10.3.3.2. Diagnostic Centers

            10.3.3.3. Clinics

            10.3.3.4. Government Organisations

        10.3.4. Market Value (US$ Mn) Forecast, By Technique

            10.3.4.1. ELISA

            10.3.4.2. Polymerase Chain Reaction

            10.3.4.3. Immunoassays

            10.3.4.4. Cell Cultures

            10.3.4.5. Others

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Disease Indication

        10.4.3. By Technique

        10.4.4. By End User

11. Europe Infectious Disease Diagnostics Market Analysis

    11.1. Introduction

        11.1.1. Y-o-Y Growth Projections, By Country

        11.1.2. Market Share & Basis Point (BPS) Analysis, By Country

    11.2. Key Trends

    11.3. Europe Market Forecast

        11.3.1. Market Value (US$ Mn) Forecast, By Country

            11.3.1.1. U.K. Absolute $ Opportunity

            11.3.1.2. Germany Absolute $ Opportunity

            11.3.1.3. Italy Absolute $ Opportunity

            11.3.1.4. France Absolute $ Opportunity

            11.3.1.5. Spain Absolute $ Opportunity

            11.3.1.6. Rest of Europe Absolute $ Opportunity

        11.3.2. Market Value (US$ Mn) Forecast, By Disease Indication

            11.3.2.1. CNS Infection

                11.3.2.1.1. Meningitis

                11.3.2.1.2. Brain Abscess

            11.3.2.2. Diarrheal Diseases

                11.3.2.2.1. Shigellosis

                11.3.2.2.2. Cholera

                11.3.2.2.3. Typhoid Fever

            11.3.2.3. Respiratory Infections

                11.3.2.3.1. Tuberculosis

                11.3.2.3.2. Influenza

                11.3.2.3.3. Bronchitis

            11.3.2.4. Blood Infections

                11.3.2.4.1. Malaria

                11.3.2.4.2. Dengue

                11.3.2.4.3. Infectious Mononucleosis

                11.3.2.4.4. Others

            11.3.2.5. Sexually Transmitted Diseases

                11.3.2.5.1. Chlamydia

                11.3.2.5.2. AIDS

                11.3.2.5.3. Syphilis

                11.3.2.5.4. Others

        11.3.3. Market Value (US$ Mn) Forecast, By End User

            11.3.3.1. Hospitals

            11.3.3.2. Diagnostic Centers

            11.3.3.3. Clinics

            11.3.3.4. Government Organisations

        11.3.4. Market Value (US$ Mn) Forecast, By Technique

            11.3.4.1. ELISA

            11.3.4.2. Polymerase Chain Reaction

            11.3.4.3. Immunoassays

            11.3.4.4. Cell Cultures

            11.3.4.5. Others

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Disease Indication

        11.4.3. By Technique

        11.4.4. By End User

12. APAC Infectious Disease Diagnostics Market Analysis

    12.1. Introduction

        12.1.1. Y-o-Y Growth Projections, By Country

        12.1.2. Market Share & Basis Point (BPS) Analysis, By Country

    12.2. Key Trends

    12.3. APAC Market Forecast

        12.3.1. Market Value (US$ Mn) Forecast, By Country

            12.3.1.1. China Absolute $ Opportunity

            12.3.1.2. India Absolute $ Opportunity

            12.3.1.3. Japan Absolute $ Opportunity

            12.3.1.4. Australia & New Zealand Absolute $ Opportunity

            12.3.1.5. Rest of APAC Absolute $ Opportunity

        12.3.2. Market Value (US$ Mn) Forecast, By Disease Indication

            12.3.2.1. CNS Infection

                12.3.2.1.1. Meningitis

                12.3.2.1.2. Brain Abscess

            12.3.2.2. Diarrheal Diseases

                12.3.2.2.1. Shigellosis

                12.3.2.2.2. Cholera

                12.3.2.2.3. Typhoid Fever

            12.3.2.3. Respiratory Infections

                12.3.2.3.1. Tuberculosis

                12.3.2.3.2. Influenza

                12.3.2.3.3. Bronchitis

            12.3.2.4. Blood Infections

                12.3.2.4.1. Malaria

                12.3.2.4.2. Dengue

                12.3.2.4.3. Infectious Mononucleosis

                12.3.2.4.4. Others

            12.3.2.5. Sexually Transmitted Diseases

                12.3.2.5.1. Chlamydia

                12.4.2.5.2. AIDS

                12.4.2.5.3. Syphilis

                12.4.2.5.4. Others

        12.3.3. Market Value (US$ Mn) Forecast, By End User

            12.3.3.1. Hospitals

            12.3.3.2. Diagnostic Centers

            12.3.3.3. Clinics

            12.3.3.4. Government Organisations

        12.3.4. Market Value (US$ Mn) Forecast, By Technique

            12.3.4.1. ELISA

            12.3.4.2. Polymerase Chain Reaction

            12.3.4.3. Immunoassays

            12.3.4.4. Cell Cultures

            12.3.4.5. Others

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Disease Indication

        12.4.3. By Technique

        12.4.4. By End User

13. MEA Infectious Disease Diagnostics Market Analysis

    13.1. Introduction

        13.1.1. Y-o-Y Growth Projections, By Country

        13.1.2. Market Share & Basis Point (BPS) Analysis, By Country

    13.2. Key Trends

    13.3. MEA Market Forecast

        13.3.1. Market Value (US$ Mn) Forecast, By Country

            13.3.2.1. GCC Countries Absolute $ Opportunity

            13.3.2.2. South Africa Absolute $ Opportunity

            13.3.2.3. Rest of MEA Absolute $ Opportunity

        13.3.2. Market Vlue (US$ Mn) Forecast, By Disease Indication

            13.3.2.1. CNS Infection

                13.3.2.1.1. Meningitis

                13.3.2.1.2. Brain Abscess

            13.3.2.2. Diarrheal Diseases

                13.3.2.2.1. Shigellosis

                13.3.2.2.2. Cholera

                13.3.2.2.3. Typhoid Fever

            13.3.2.3. Respiratory Infections

                13.3.2.3.1 Tuberculosis

                13.3.2.3.2. Influenza

                13.3.2.3.3. Bronchitis

            13.3.2.4. Blood Infections

                13.3.2.4.1. Malaria

                13.3.2.4.2. Dengue

                13.3.2.4.3. Infectious Mononucleosis

                13.3.2.4.4. Others

            13.3.2.5. Sexually Transmitted Diseases

                13.3.2.5.1. Chlamydia

                13.3.2.5.2. AIDS

                13.3.2.5.3. Syphilis

                13.3.2.5.4. Others

        13.3.3. Market Value (US$ Mn) Forecast, By End User

            13.3.3.1. Hospitals

            13.3.3.2. Diagnostic Centers

            13.3.3.3. Clinics

            13.3.3.4. Government Organisations

        13.4.4. Market Value (US$ Mn) Forecast, By

        13.4.5. Market Value (US$ Mn) Forecast, By Technique

            13.4.5.1. ELISA

            13.4.5.2. Polymerase Chain Reaction

            13.4.5.3. Immunoassays

            13.4.5.4. Cell Cultures

            13.4.5.5. Others

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Disease Indication

        13.4.3. By Technique

        13.4.4. By End User

14. Competition Landscape

    14.1. Competition Dashboard

    14.2. Company Share Analysis

    14.3. Company Profiles

        14.3.1. Revenue

        14.3.2. Products/Brand Offerings

        14.3.3. Key developments

        14.3.4. SWOT Analysis

    14.4. Company Profiled

        14.4.1. Becton Dickinson & Company

        14.4.2. Cepheid, Inc.

        14.4.4. Abbott Laboratories

        14.4.4. bioMerieux SA

        14.4.5. Hologic, Inc.

        14.4.6. Danaher Corporation

        14.4.7. Thermo Fisher Scientific, Inc.

        14.4.8. Roche Diagnostics

        14.4.9. Alera Inc.

        14.4.9. DiaSorin S.p.A.

        14.4.11. Quidel Corporation

        14.4.12. Bio-Rad Laboratories, Inc.

Find Out More about the Report Coverage

List of Tables

List of Tables

Table 01: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By End User, 2016–2024

Table 02: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Disease Indication, 2016–2024

Table 03: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By CNS Infection Disease Indication Segment, 2016–2024

Table 04: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Diarrhoeal Disease Indication Segment, 2016–2024

Table: 05 Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Respiratory Infections Disease Indication Segment, 2016–2024

Table 06: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Blood Infections Disease Indication Segment, 2016–2024

Table 07: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By STDs Disease Indication Segment, 2016–2024

Table 08: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Technique, 2016–2024

Table 09: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Region, 2016–2024

Table 10: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Country, 2016–2024

Table 11: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Disease Indication, 2016–2024

Table 12: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By CNS Infection Disease Indication Segment, 2016–2024

Table 13: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Diarrhoeal Disease Indication Segment, 2016–2024

Table 14: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Respiratory Infections Disease Indication Segment, 2016–2024

Table 15: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Blood Infections Disease Indication Segment, 2016–2024

Table 16: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By STDs Disease Indication Segment, 2016–2024

Table 17: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Technique, 2016–2024

Table 18: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By End User, 2016–2024

Table 19: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Country, 2016–2024

Table 20: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Disease Indication, 2016–2024

Table 21: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By CNS Infection Disease Indication Segment, 2016–2024

Table 22: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Diarrhoeal Disease Indication Segment, 2016–2024

Table 23: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Respiratory Infections Disease Indication Segment, 2016–2024

Table 24: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Blood Infections Disease Indication Segment, 2016–2024

Table 25: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By STDs Disease Indication Segment, 2016–2024

Table 26: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Technique, 2016–2024

Table 27: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By End User, 2016–2024

Table 28: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Country, 2016–2024

Table 29: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Disease Indication, 2016–2024

Table 30: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By CNS Infection Disease Indication Segment, 2016–2024

Table 31: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Diarrhoeal Disease Indication Segment, 2016–2024

Table 32: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Respiratory Infections Disease Indication Segment, 2016–2024

Table 33: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Blood Infections Disease Indication Segment, 2016–2024

Table 34: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By STDs Disease Indication Segment, 2016–2024

Table 35: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Technique, 2016–2024

Table 36: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By End User, 2016–2024

Table 37: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Country, 2016–2024

Table 38: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Disease Indication, 2016–2024

Table 39: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By CNS Infection Disease Indication Segment, 2016–2024

Table 40: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Diarrhoeal Disease Indication Segment, 2016–2024

Table 41: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Respiratory Infections Disease Indication Segment, 2016–2024

Table 42: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Blood Infections Disease Indication Segment, 2016–2024

Table 43: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By STDs Disease Indication Segment, 2016–2024

Table 44: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Technique, 2016–2024

Table 45: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By End User, 2016–2024

Table 46: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Country, 2016–2024

Table 47: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Disease Indication, 2016–2024

Table 48: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By CNS Infection Disease Indication Segment, 2016–2024

Table 49: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Diarrhoeal Disease Indication Segment, 2016–2024

Table 50: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Respiratory Infections Disease Indication Segment, 2016–2024

Table 51: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Blood Infections Disease Indication Segment, 2016–2024

Table 52: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By STDs Disease Indication Segment, 2016–2024

Table 53: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Technique, 2016–2024

Table 54: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By End User, 2016–2024

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

List of Figures

Figure 01: Global Infectious Disease Diagnostics Market – Scenario Forecast, 2015–2024 (US$ Mn)

Figure 02: Global Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024

Figure 03: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024

Figure 04: Global Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024

Figure 05: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Disease Indication, 2016–2024

Figure 06: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Disease Indication, 2016–2024

Figure 07: Global Infectious Disease Diagnostics Market Share Analysis (%) By CNS Infections, 2016–2024

Figure 08: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By CNS Infections, 2016–2024

Figure 09: Global Infectious Disease Diagnostics Market Attractiveness Analysis By CNS Infection Segment, 2016–2024

Figure 10: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By CNS Infection Segment, 2016–2024

Figure 11: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By CNS Infection Segment, 2016–2024

Figure 12: Global Infectious Disease Diagnostics Market Share Analysis (%) By Diarrheal Infection Segment, 2016–2024

Figure13: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Diarrheal Infection Segment, 2016–2024

Figure 14: Global Infectious Disease Diagnostics Market Attractiveness Analysis By Diarrheal Infection Segment, 2016–2024

Figure 15: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Diarrheal Infection Segment, 2016–2024

Figure 16: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Diarrheal Infection Segment, 2016–2024

Figure 17: Global Infectious Disease Diagnostics Market Share Analysis (%) By Respiratory Infection Segment, 2016–2024

Figure 18: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Respiratory Infection Segment, 2016–2024

Figure 19: Global Infectious Disease Diagnostics Market Attractiveness Analysis By Respiratory Infection Segment, 2016–2024

Figure 20: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Respiratory Infection Segment, 2016–2024

Figure 21: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Respiratory Infection Segment, 2016–2024

Figure 22: Global Infectious Disease Diagnostics Market Share Analysis (%) By Blood Infection Segment, 2016–2024

Figure 23: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Blood Infection Segment, 2016–2024

Figure 24: Global Infectious Disease Diagnostics Market Attractiveness Analysis By Blood Infection Segment, 2016–2024

Figure 25: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Blood Infection Segment, 2016–2024

Figure 26: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Blood Infection Segment, 2016–2024

Figure 27: Global Infectious Disease Diagnostics Market Share Analysis (%) By STDs Segment, 2016–2024

Figure 28: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By STDs Segment, 2016–2024

Figure 29: Global Infectious Disease Diagnostics Market Attractiveness Analysis By STDs Segment, 2016–2024

Figure 30: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By STDs Segment, 2016–2024

Figure 31: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By STDs Segment, 2016–2024

Figure 32: Global Infectious Disease Diagnostics Market Share Analysis (%) By Technique, 2016–2024

Figure 33: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Technique, 2016–2024

Figure 34: Global Infectious Disease Diagnostics Market Attractiveness Analysis Technique, 2016–2024

Figure 35: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Cell Cultures Technique Segment, 2016–2024

Figure 36: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Cell Cultures Technique Segment, 2016–2024

Figure 37: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Immunoassays Technique Segment, 2016–2024

Figure 38: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Immunoassays Technique Segment, 2016–2024

Figure 39: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By ELISA Technique Segment, 2016–2024

Figure 40: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By ELISA Technique Segment, 2016–2024

Figure 41: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By PCR Technique Segment, 2016–2024

Figure 42: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By PCR Technique Segment, 2016–2024

Figure 43: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Others Technique Segment, 2016–2024

Figure 44: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Others Technique Segment, 2016–2024

Figure 45: Global Infectious Disease Diagnostics Market Share Analysis (%) By End User, 2016–2024

Figure 46: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By End User, 2016–2024

Figure 47: Global Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024

Figure 48: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Hospitals End User Segment, 2016–2024

Figure 49: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Hospitals End User Segment, 2016–2024

Figure 50: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Diagnostic Centers End User Segment, 2016–2024

Figure 51: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Diagnostic Centers End User Segment, 2016–2024

Figure 52: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Clinics End User Segment, 2016–2024

Figure 53: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Clinics End User Segment, 2016–2024

Figure 54: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Government Organizations End User Segment, 2016–2024

Figure 55: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Government Organizations End User Segment, 2016–2024

Figure 56: Infectious Disease Diagnostics Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024

Figure 57: Global Infectious Disease Diagnostics Market Share Analysis (%) By Region, 2016–2024

Figure 58: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Region, 2016–2024

Figure 59: Global Infectious Disease Diagnostics Market Attractiveness Analysis By Region, 2016–2024

Figure 60: North America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024

Figure 61: North America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024

Figure 62: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024

Figure 63: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024

Figure 64: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024

Figure 65: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024

Figure 66: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024

Figure 67: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024

Figure 68: MEA Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024

Figure 69: MEA Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024

Figure 70: North America Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024

Figure 71: North America Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024

Figure 72: North America Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024

Figure 73: North America Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024

Figure 74: North America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By U.S., 2016–2024

Figure 75: North America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By U.S., 2016–2024

Figure 76: North America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Canada, 2016–2024

Figure 77: North America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Canada, 2016–2024

Figure 78: North America Infectious Disease Diagnostics Market Attractiveness Analysis, By Country, 2016–2024

Figure 79: North America Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024

Figure 80: North America Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024

Figure 81: North America Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024

Figure 82: Latin America Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024

Figure 83: Latin America Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024

Figure 84: Latin America Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024

Figure 85: Latin America Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024

Figure 86: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Brazil, 2016–2024

Figure 87: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Brazil, 2016–2024

Figure 88: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Mexico, 2016–2024

Figure 89: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Mexico, 2016–2024

Figure 90: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Argentina, 2016–2024

Figure 91: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Argentina, 2016–2024

Figure 92: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Rest of Latin America, 2016–2024

Figure 93: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Rest of Latin America, 2016–2024

Figure 94: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, By Country, 2016–2024

Figure 95: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024

Figure 96: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024

Figure 97: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024

Figure 98: Europe Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024

Figure 99: Europe Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024

Figure 100: Europe Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024

Figure 101: Europe Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024

Figure 102: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By The U.K., 2016–2024

Figure 103: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By The U.K., 2016–2024

Figure 104: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Germany, 2016–2024

Figure 105: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Germany, 2016–2024

Figure 106: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By France, 2016–2024

Figure 107: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By France, 2016–2024

Figure 108: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Italy, 2016–2024

Figure 109: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Italy, 2016–2024

Figure 110: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Spain, 2016–2024

Figure 111: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Spain, 2016–2024

Figure 112: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Rest of Europe, 2016–2024

Figure 113: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Rest of Europe, 2016–2024

Figure 114: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, By Country, 2016–2024

Figure 115: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024

Figure 116: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024

Figure 117: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024

Figure 118: APAC Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024

Figure 119: APAC Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024

Figure 120: APAC Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024

Figure 121: APAC Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024

Figure 122: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By China, 2016–2024

Figure 123: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By China, 2016–2024

Figure 124: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Japan, 2016–2024

Figure 125: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Japan, 2016–2024

Figure 126: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By India, 2016–2024

Figure 127: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By India, 2016–2024

Figure 128: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Australia & New Zealand, 2016–2024

Figure 129: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Australia & New Zealand, 2016–2024

Figure 130: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Rest of APAC, 2016–2024

Figure 131: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Rest of APAC, 2016–2024

Figure 133: APAC Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024

Figure 134: APAC Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024

Figure 135: APAC Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024

Figure 136: MEA Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024

Figure 137: MEA Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024

Figure 138: MEA Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024

Figure 139: MEA Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024

Figure 140: MEA Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By GCC Countries, 2016–2024

Figure 141: MEA Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By GCC Countries, 2016–2024

Figure 142: MEA Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By South Africa, 2016–2024

Figure 143: MEA Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By South Africa, 2016–2024

Figure 144: MEA Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Rest of MEA, 2016–2024

Figure 145: MEA Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Rest of MEA, 2016–2024

Figure 146: MEA Infectious Disease Diagnostics Market Attractiveness Analysis, By Country, 2016–2024

Figure 147: MEA Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024

Figure 148: MEA Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024

Figure 149: MEA Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024

Figure 150: Market Share of Prominent Key Players: Infectious Diseases Market, 2015

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Recommendations

White Spirit Market

White Spirits Market are of four types - Type 1, Type 2, Type 3, and Type 0, which are categorized on their aromatic content basis. White spirits are consumed in a wide range of applications such as paint thinners, cleaning solvents, degreasing solvents, fuels, and disinfectants, among others..

EMEA Dearomatic Solvents Market

Global De-aromatic solvents market is expected to register a CAGR of 5.0% over the forecast period (2016 – 2024), to reach valuation of US$ 556.0 Mn by 2024.

Polyester Polyols Market

Polyester Polyols Market was valued at US$ 7,788.7 Mn in 2017 and is projected to rise to a valuation of US$ 11,963.6 Mn by the end of 2025..

De-aromatic Solvents Market

The global de-aromatic solvents market is estimated to expand at a CAGR of more than 6% over the forecast period of 2021-2031..

Our Clients

Our Clients